EUVIMEDEUVIMED entdecken
Crossref

Genotoxicity Assessment of Hypericum perforatum Dry Extracts in the Ames Test Based on the “Bracketing and Matrixing” Concept

Jens Flade iD, Olaf Kelber iD, Karen Nieber, Björn Feistel

Planta Medica · 01.05.2026 · 92 (06) · 639-646

DOI: 10.1055/a-2727-1619 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Planta Medica, erschienen am 01.05.2026. Verfasst von Jens Flade und 3 weiteren Autor:innen. Beteiligte Einrichtung: Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Postgraduate Study of Toxicology and Environmental Protection, Leipzig University, Leipzig, …. Hauptthemen laut MEDLINE: Hypericum, Plant Extracts. Die Arbeit nennt 33 Literaturangaben. Gefördert von: Kooperation Phytopharmaka GbR.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

HMPs derived from Hypericum perforatum, herba (St. Johnʼs wort) play an important role in treating mild to moderate depressive episodes and mental exhaustion, for example. The genotoxic safety of these HMPs has already been assessed and reviewed in recent years. However, further data on the genotoxic potential of Hypericum perforatum, herba preparations would allow the evaluation of the therapeutic safety of the herbal drug and preparations thereof in accordance with the genotoxicity guideline of the HMPC of the EMA. Accordingly, their genotoxic potential was tested using the “bracketing and matrixing” concept, whereby extracts are tested at and between the extremes of their extraction solvents (ranging in strength from polar to non-polar) to cover the entire spectrum of the drugʼs constituents. In the present study, five dry extracts of Hypericum perforatum, herba, representing the full range of potential extraction solvent polarities (water, ethanol 50% (v/v), methanol 80% (v/v), ethanol 80% (v/v), and n-heptane) were tested using the Ames test, according to the OECD and HMPC guidelines. No mutagenic effects were observed for any of the five test strains in two independent experiments (plate incorporation test and pre-incubation test) each carried out with and without metabolic activation, even at the highest concentrations (5000 µg/plate), in accordance with the OECD guideline No. 471.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HypericumPlant ExtractsMutagenicity TestsSalmonella typhimuriumSolvents

Substanzen

Plant ExtractsSolvents

Autor:innen und Institutionen

  • Rudolf-Boehm-Institut für Pharmakologie und Toxikologie, Postgraduate Study of Toxicology and Environmental Protection, Leipzig University, Leipzig, Germany.
  • Phyto & Biotics Technology Platform, Bayer Consumer Health, Steigerwald Arzneimittelwerk GmbH, Darmstadt, Germany.
  • Kooperation Phytopharmaka GbR, Bonn, Germany.
  • Institute for Pharmacy, Leipzig University, Leipzig, Germany.
  • Finzelberg GmbH & Co. KG, Andernach, Germany.

ORCID-Profile: Jens Flade, Olaf Kelber

Förderung

  • Kooperation Phytopharmaka GbR

Zitieren

APA

Flade, J., Kelber, O., Nieber, K., & Feistel, B. (2026). Genotoxicity Assessment of Hypericum perforatum Dry Extracts in the Ames Test Based on the “Bracketing and Matrixing” Concept. Planta Medica, 92(06), 639-646. https://doi.org/10.1055/a-2727-1619

Vancouver

Flade J, Kelber O, Nieber K, Feistel B. Genotoxicity Assessment of Hypericum perforatum Dry Extracts in the Ames Test Based on the “Bracketing and Matrixing” Concept. Planta Medica. 2026;92(06):639-646. doi:10.1055/a-2727-1619

BibTeX
@article{Flade2026,
  author = {Flade, Jens and Kelber, Olaf and Nieber, Karen and Feistel, Björn},
  title = {Genotoxicity Assessment of Hypericum perforatum Dry Extracts in the Ames Test Based on the “Bracketing and Matrixing” Concept},
  journal = {Planta Medica},
  year = {2026},
  volume = {92},
  number = {06},
  pages = {639--646},
  doi = {10.1055/a-2727-1619}
}
Kostenlos starten →